Startseite Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis

Veröffentlicht/Copyright: 31. Oktober 2007
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 45 Heft 11

Abstract

Background: Neonatal infection remains a major diagnostic problem because of non-specific clinical signs and symptoms, as well as low sensitivity and specificity of routine laboratory tests. C-reactive protein (CRP), white blood cell count, absolute neutrophil count and immature/total neutrophil ratio are the most widely used tests in the diagnosis of sepsis and provide useful information, but none of these has demonstrated to be reliable in detecting all septic infants. Procalcitonin (PCT) has been suggested as a potentially useful laboratory test performed in umbilical cord blood when perinatal bacterial sepsis is under investigation.

Methods: In this study, the reference interval for umbilical cord blood serum PCT was established for the first time by Time-Resolved Amplified Cryptate Emission (TRACE) technology.

Results: The reference interval for PCT in umbilical cord blood serum ranged from 0.04 to 0.43 μg/L in 168 non-infected newborn infants (95% CI 0.02–0.06 and 0.35–0.60 μg/L, respectively). Cord blood serum PCT correctly classified one infected patient out of 90 newborn infants at risk of vertically transmitted sepsis and identified another neonate as a potentially infected patient despite having negative blood cultures. However, cord blood CRP misclassified 21 out of the 90 patients as infected neonates.

Conclusions: Cord blood PCT measured by TRACE is a potentially more useful early marker of neonatal sepsis than cord blood CRP.

Clin Chem Lab Med 2007;45:1531–5.


Corresponding author: Belén Prieto García, PhD, Hospital Universitario Central de Asturias, c/ Celestino Villamil, s/n – 33006 Oviedo, Spain Phone/Fax: +34-985-108073,

Received: 2007-4-24
Accepted: 2007-7-8
Published Online: 2007-10-31
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Current state and future directions of neurochemical biomarkers for Alzheimer's disease
  2. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations
  3. Analysis of ferritin genes in Parkinson disease
  4. Multimers and adiponectin gene 276G>T polymorphism in the Japanese population residing in rural areas
  5. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp.
  6. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease
  7. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients
  8. How useful are housekeeping genes? Variable expression in melanoma metastases
  9. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy
  10. Isobutyryl-CoA dehydrogenase deficiency with a novel ACAD8 gene mutation detected by tandem mass spectrometry newborn screening
  11. Circulating levels of osteoprotegerin and receptor activator of NF-κB ligand in patients with chronic renal failure
  12. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor
  13. Impact of rosiglitazone on the expression of β3-AR in the stable cell lines expressed β3-AR gene
  14. Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid
  15. Redefining functional sensitivity of thyroglobulin assay on Immulite platform: implications in thyroid cancer management
  16. Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age
  17. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis
  18. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function
  19. Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro
  20. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit
  21. Validation study of Axis-Shield carbohydrate-deficient transferrin (CDT) on ARCHITECT® chemistry analyzer
  22. High free serum acrolein levels in bacterial infection and other disease states associated with oxidative stress: a potential biomarker?
  23. Increased serum S100B protein in chronic schizophrenic patients in Korea
  24. Addendum to the recent report of EC4 on the accreditation of medical laboratories in the European Union
  25. Reply to the letter written by Haeckel
  26. The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum
  27. Transthyretin, nutrition, and inflammation: response to Dr. Bernstein
  28. Erratum
Heruntergeladen am 29.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.304/html?lang=de
Button zum nach oben scrollen